Global Label-free Array Systems Industry
Global Label-free Array Systems Market to Reach $1.8 Billion by 2027
NEW YORK, Nov. 11, 2020 /PRNewswire/ -- Amid the COVID-19 crisis, the global market for Label-free Array Systems estimated at US$1.3 Billion in the year 2020, is projected to reach a revised size of US$1.8 Billion by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027. Surface Plasmon Resonance (SPR), one of the segments analyzed in the report, is projected to record a 5.5% CAGR and reach US$1.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Bio-layer Interferometry (BLI) segment is readjusted to a revised 4.8% CAGR for the next 7-year period.
Read the full report: https://www.reportlinker.com/p05961007/?utm_source=PRN
The U.S. Market is Estimated at $375.2 Million, While China is Forecast to Grow at 5.1% CAGR
The Label-free Array Systems market in the U.S. is estimated at US$375.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$323.5 Million by the year 2027 trailing a CAGR of 5.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5% and 4.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.
Cellular Dielectric Spectroscopy (CDS) Segment to Record 5.2% CAGR
In the global Cellular Dielectric Spectroscopy (CDS) segment, USA, Canada, Japan, China and Europe will drive the 5.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$58.5 Million in the year 2020 will reach a projected size of US$84.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$204.3 Million by the year 2027.We bring years of research experience to this 9th edition of our report. The 235-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others,
- Agilent Technologies, Inc.
- Attana AB
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche AG
- ForteBio
- GWC Technologies
- Molecular Devices LLC
- PerkinElmer, Inc.
- Riot Blockchain, Inc.
Read the full report: https://www.reportlinker.com/p05961007/?utm_source=PRN
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Label-free Array Systems Competitor Market Share Scenario
Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Label-free Array
Systems by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027
Table 2: World Historic Review for Label-free Array Systems by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
Table 3: World 15-Year Perspective for Label-free Array Systems
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2012, 2020 & 2027
Table 4: World Current & Future Analysis for Surface Plasmon
Resonance (SPR) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027
Table 5: World Historic Review for Surface Plasmon Resonance
(SPR) by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
Table 6: World 15-Year Perspective for Surface Plasmon
Resonance (SPR) by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2012, 2020 & 2027
Table 7: World Current & Future Analysis for Bio-layer
Interferometry (BLI) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027
Table 8: World Historic Review for Bio-layer Interferometry
(BLI) by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
Table 9: World 15-Year Perspective for Bio-layer Interferometry
(BLI) by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027
Table 10: World Current & Future Analysis for Cellular
Dielectric Spectroscopy (CDS) by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027
Table 11: World Historic Review for Cellular Dielectric
Spectroscopy (CDS) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019
Table 12: World 15-Year Perspective for Cellular Dielectric
Spectroscopy (CDS) by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
Table 13: World Current & Future Analysis for Quartz Crystal
Microbalance by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027
Table 14: World Historic Review for Quartz Crystal Microbalance
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
Table 15: World 15-Year Perspective for Quartz Crystal
Microbalance by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2012, 2020 & 2027
Table 16: World Current & Future Analysis for Drug Discovery by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027
Table 17: World Historic Review for Drug Discovery by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
Table 18: World 15-Year Perspective for Drug Discovery by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 19: World Current & Future Analysis for Antibody
Characterization and Development by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027
Table 20: World Historic Review for Antibody Characterization
and Development by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019
Table 21: World 15-Year Perspective for Antibody
Characterization and Development by Geographic Region -
Percentage Breakdown of Value Sales for USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World for Years 2012,
2020 & 2027
Table 22: World Current & Future Analysis for Protein Interface
Analysis by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027
Table 23: World Historic Review for Protein Interface Analysis
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
Table 24: World 15-Year Perspective for Protein Interface
Analysis by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027
Table 25: World Current & Future Analysis for Protein Complex
and Cascade Analysis by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027
Table 26: World Historic Review for Protein Complex and Cascade
Analysis by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019
Table 27: World 15-Year Perspective for Protein Complex and
Cascade Analysis by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2012, 2020 & 2027
Table 28: World Current & Future Analysis for R&D Laboratories
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027
Table 29: World Historic Review for R&D Laboratories by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
Table 30: World 15-Year Perspective for R&D Laboratories by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 31: World Current & Future Analysis for Contract Research
Organizations (CROs) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027
Table 32: World Historic Review for Contract Research
Organizations (CROs) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019
Table 33: World 15-Year Perspective for Contract Research
Organizations (CROs) by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
Table 34: World Current & Future Analysis for Agriculture
Research Institutes by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027
Table 35: World Historic Review for Agriculture Research
Institutes by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019
Table 36: World 15-Year Perspective for Agriculture Research
Institutes by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027
Table 37: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027
Table 38: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
Table 39: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Label-free Array Systems Market Share (in %) by Company:
2019 & 2025
Market Analytics
Table 40: USA Current & Future Analysis for Label-free Array
Systems by Technology - Surface Plasmon Resonance (SPR),
Bio-layer Interferometry (BLI), Cellular Dielectric
Spectroscopy (CDS) and Quartz Crystal Microbalance -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027
Table 41: USA Historic Review for Label-free Array Systems by
Technology - Surface Plasmon Resonance (SPR), Bio-layer
Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS)
and Quartz Crystal Microbalance Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
Table 42: USA 15-Year Perspective for Label-free Array Systems
by Technology - Percentage Breakdown of Value Sales for Surface
Plasmon Resonance (SPR), Bio-layer Interferometry (BLI),
Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal
Microbalance for the Years 2012, 2020 & 2027
Table 43: USA Current & Future Analysis for Label-free Array
Systems by Application - Drug Discovery, Antibody
Characterization and Development, Protein Interface Analysis
and Protein Complex and Cascade Analysis - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
Table 44: USA Historic Review for Label-free Array Systems by
Application - Drug Discovery, Antibody Characterization and
Development, Protein Interface Analysis and Protein Complex and
Cascade Analysis Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019
Table 45: USA 15-Year Perspective for Label-free Array Systems
by Application - Percentage Breakdown of Value Sales for Drug
Discovery, Antibody Characterization and Development, Protein
Interface Analysis and Protein Complex and Cascade Analysis for
the Years 2012, 2020 & 2027
Table 46: USA Current & Future Analysis for Label-free Array
Systems by End-Use - R&D Laboratories, Contract Research
Organizations (CROs), Agriculture Research Institutes and Other
End-Uses - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027
Table 47: USA Historic Review for Label-free Array Systems by
End-Use - R&D Laboratories, Contract Research Organizations
(CROs), Agriculture Research Institutes and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019
Table 48: USA 15-Year Perspective for Label-free Array Systems
by End-Use - Percentage Breakdown of Value Sales for R&D
Laboratories, Contract Research Organizations (CROs),
Agriculture Research Institutes and Other End-Uses for the
Years 2012, 2020 & 2027
CANADA
Table 49: Canada Current & Future Analysis for Label-free Array
Systems by Technology - Surface Plasmon Resonance (SPR),
Bio-layer Interferometry (BLI), Cellular Dielectric
Spectroscopy (CDS) and Quartz Crystal Microbalance -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027
Table 50: Canada Historic Review for Label-free Array Systems
by Technology - Surface Plasmon Resonance (SPR), Bio-layer
Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS)
and Quartz Crystal Microbalance Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
Table 51: Canada 15-Year Perspective for Label-free Array
Systems by Technology - Percentage Breakdown of Value Sales for
Surface Plasmon Resonance (SPR), Bio-layer Interferometry
(BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz
Crystal Microbalance for the Years 2012, 2020 & 2027
Table 52: Canada Current & Future Analysis for Label-free Array
Systems by Application - Drug Discovery, Antibody
Characterization and Development, Protein Interface Analysis
and Protein Complex and Cascade Analysis - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
Table 53: Canada Historic Review for Label-free Array Systems
by Application - Drug Discovery, Antibody Characterization and
Development, Protein Interface Analysis and Protein Complex and
Cascade Analysis Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019
Table 54: Canada 15-Year Perspective for Label-free Array
Systems by Application - Percentage Breakdown of Value Sales
for Drug Discovery, Antibody Characterization and Development,
Protein Interface Analysis and Protein Complex and Cascade
Analysis for the Years 2012, 2020 & 2027
Table 55: Canada Current & Future Analysis for Label-free Array
Systems by End-Use - R&D Laboratories, Contract Research
Organizations (CROs), Agriculture Research Institutes and Other
End-Uses - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027
Table 56: Canada Historic Review for Label-free Array Systems
by End-Use - R&D Laboratories, Contract Research Organizations
(CROs), Agriculture Research Institutes and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019
Table 57: Canada 15-Year Perspective for Label-free Array
Systems by End-Use - Percentage Breakdown of Value Sales for
R&D Laboratories, Contract Research Organizations (CROs),
Agriculture Research Institutes and Other End-Uses for the
Years 2012, 2020 & 2027
JAPAN
Table 58: Japan Current & Future Analysis for Label-free Array
Systems by Technology - Surface Plasmon Resonance (SPR),
Bio-layer Interferometry (BLI), Cellular Dielectric
Spectroscopy (CDS) and Quartz Crystal Microbalance -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027
Table 59: Japan Historic Review for Label-free Array Systems by
Technology - Surface Plasmon Resonance (SPR), Bio-layer
Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS)
and Quartz Crystal Microbalance Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
Table 60: Japan 15-Year Perspective for Label-free Array
Systems by Technology - Percentage Breakdown of Value Sales for
Surface Plasmon Resonance (SPR), Bio-layer Interferometry
(BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz
Crystal Microbalance for the Years 2012, 2020 & 2027
Table 61: Japan Current & Future Analysis for Label-free Array
Systems by Application - Drug Discovery, Antibody
Characterization and Development, Protein Interface Analysis
and Protein Complex and Cascade Analysis - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
Table 62: Japan Historic Review for Label-free Array Systems by
Application - Drug Discovery, Antibody Characterization and
Development, Protein Interface Analysis and Protein Complex and
Cascade Analysis Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019
Table 63: Japan 15-Year Perspective for Label-free Array
Systems by Application - Percentage Breakdown of Value Sales
for Drug Discovery, Antibody Characterization and Development,
Protein Interface Analysis and Protein Complex and Cascade
Analysis for the Years 2012, 2020 & 2027
Table 64: Japan Current & Future Analysis for Label-free Array
Systems by End-Use - R&D Laboratories, Contract Research
Organizations (CROs), Agriculture Research Institutes and Other
End-Uses - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027
Table 65: Japan Historic Review for Label-free Array Systems by
End-Use - R&D Laboratories, Contract Research Organizations
(CROs), Agriculture Research Institutes and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019
Table 66: Japan 15-Year Perspective for Label-free Array
Systems by End-Use - Percentage Breakdown of Value Sales for
R&D Laboratories, Contract Research Organizations (CROs),
Agriculture Research Institutes and Other End-Uses for the
Years 2012, 2020 & 2027
CHINA
Table 67: China Current & Future Analysis for Label-free Array
Systems by Technology - Surface Plasmon Resonance (SPR),
Bio-layer Interferometry (BLI), Cellular Dielectric
Spectroscopy (CDS) and Quartz Crystal Microbalance -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027
Table 68: China Historic Review for Label-free Array Systems by
Technology - Surface Plasmon Resonance (SPR), Bio-layer
Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS)
and Quartz Crystal Microbalance Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
Table 69: China 15-Year Perspective for Label-free Array
Systems by Technology - Percentage Breakdown of Value Sales for
Surface Plasmon Resonance (SPR), Bio-layer Interferometry
(BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz
Crystal Microbalance for the Years 2012, 2020 & 2027
Table 70: China Current & Future Analysis for Label-free Array
Systems by Application - Drug Discovery, Antibody
Characterization and Development, Protein Interface Analysis
and Protein Complex and Cascade Analysis - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
Table 71: China Historic Review for Label-free Array Systems by
Application - Drug Discovery, Antibody Characterization and
Development, Protein Interface Analysis and Protein Complex and
Cascade Analysis Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019
Table 72: China 15-Year Perspective for Label-free Array
Systems by Application - Percentage Breakdown of Value Sales
for Drug Discovery, Antibody Characterization and Development,
Protein Interface Analysis and Protein Complex and Cascade
Analysis for the Years 2012, 2020 & 2027
Table 73: China Current & Future Analysis for Label-free Array
Systems by End-Use - R&D Laboratories, Contract Research
Organizations (CROs), Agriculture Research Institutes and Other
End-Uses - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027
Table 74: China Historic Review for Label-free Array Systems by
End-Use - R&D Laboratories, Contract Research Organizations
(CROs), Agriculture Research Institutes and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019
Table 75: China 15-Year Perspective for Label-free Array
Systems by End-Use - Percentage Breakdown of Value Sales for
R&D Laboratories, Contract Research Organizations (CROs),
Agriculture Research Institutes and Other End-Uses for the
Years 2012, 2020 & 2027
EUROPE
Market Facts & Figures
European Label-free Array Systems Market: Competitor Market
Share Scenario (in %) for 2019 & 2025
Market Analytics
Table 76: Europe Current & Future Analysis for Label-free Array
Systems by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2020 through 2027
Table 77: Europe Historic Review for Label-free Array Systems
by Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019
Table 78: Europe 15-Year Perspective for Label-free Array
Systems by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2012, 2020 & 2027
Table 79: Europe Current & Future Analysis for Label-free Array
Systems by Technology - Surface Plasmon Resonance (SPR),
Bio-layer Interferometry (BLI), Cellular Dielectric
Spectroscopy (CDS) and Quartz Crystal Microbalance -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027
Table 80: Europe Historic Review for Label-free Array Systems
by Technology - Surface Plasmon Resonance (SPR), Bio-layer
Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS)
and Quartz Crystal Microbalance Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
Table 81: Europe 15-Year Perspective for Label-free Array
Systems by Technology - Percentage Breakdown of Value Sales for
Surface Plasmon Resonance (SPR), Bio-layer Interferometry
(BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz
Crystal Microbalance for the Years 2012, 2020 & 2027
Table 82: Europe Current & Future Analysis for Label-free Array
Systems by Application - Drug Discovery, Antibody
Characterization and Development, Protein Interface Analysis
and Protein Complex and Cascade Analysis - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
Table 83: Europe Historic Review for Label-free Array Systems
by Application - Drug Discovery, Antibody Characterization and
Development, Protein Interface Analysis and Protein Complex and
Cascade Analysis Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019
Table 84: Europe 15-Year Perspective for Label-free Array
Systems by Application - Percentage Breakdown of Value Sales
for Drug Discovery, Antibody Characterization and Development,
Protein Interface Analysis and Protein Complex and Cascade
Analysis for the Years 2012, 2020 & 2027
Table 85: Europe Current & Future Analysis for Label-free Array
Systems by End-Use - R&D Laboratories, Contract Research
Organizations (CROs), Agriculture Research Institutes and Other
End-Uses - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027
Table 86: Europe Historic Review for Label-free Array Systems
by End-Use - R&D Laboratories, Contract Research Organizations
(CROs), Agriculture Research Institutes and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019
Table 87: Europe 15-Year Perspective for Label-free Array
Systems by End-Use - Percentage Breakdown of Value Sales for
R&D Laboratories, Contract Research Organizations (CROs),
Agriculture Research Institutes and Other End-Uses for the
Years 2012, 2020 & 2027
FRANCE
Table 88: France Current & Future Analysis for Label-free Array
Systems by Technology - Surface Plasmon Resonance (SPR),
Bio-layer Interferometry (BLI), Cellular Dielectric
Spectroscopy (CDS) and Quartz Crystal Microbalance -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027
Table 89: France Historic Review for Label-free Array Systems
by Technology - Surface Plasmon Resonance (SPR), Bio-layer
Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS)
and Quartz Crystal Microbalance Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
Table 90: France 15-Year Perspective for Label-free Array
Systems by Technology - Percentage Breakdown of Value Sales for
Surface Plasmon Resonance (SPR), Bio-layer Interferometry
(BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz
Crystal Microbalance for the Years 2012, 2020 & 2027
Table 91: France Current & Future Analysis for Label-free Array
Systems by Application - Drug Discovery, Antibody
Characterization and Development, Protein Interface Analysis
and Protein Complex and Cascade Analysis - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
Table 92: France Historic Review for Label-free Array Systems
by Application - Drug Discovery, Antibody Characterization and
Development, Protein Interface Analysis and Protein Complex and
Cascade Analysis Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019
Table 93: France 15-Year Perspective for Label-free Array
Systems by Application - Percentage Breakdown of Value Sales
for Drug Discovery, Antibody Characterization and Development,
Protein Interface Analysis and Protein Complex and Cascade
Analysis for the Years 2012, 2020 & 2027
Table 94: France Current & Future Analysis for Label-free Array
Systems by End-Use - R&D Laboratories, Contract Research
Organizations (CROs), Agriculture Research Institutes and Other
End-Uses - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027
Table 95: France Historic Review for Label-free Array Systems
by End-Use - R&D Laboratories, Contract Research Organizations
(CROs), Agriculture Research Institutes and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019
Table 96: France 15-Year Perspective for Label-free Array
Systems by End-Use - Percentage Breakdown of Value Sales for
R&D Laboratories, Contract Research Organizations (CROs),
Agriculture Research Institutes and Other End-Uses for the
Years 2012, 2020 & 2027
GERMANY
Table 97: Germany Current & Future Analysis for Label-free
Array Systems by Technology - Surface Plasmon Resonance (SPR),
Bio-layer Interferometry (BLI), Cellular Dielectric
Spectroscopy (CDS) and Quartz Crystal Microbalance -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027
Table 98: Germany Historic Review for Label-free Array Systems
by Technology - Surface Plasmon Resonance (SPR), Bio-layer
Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS)
and Quartz Crystal Microbalance Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
Table 99: Germany 15-Year Perspective for Label-free Array
Systems by Technology - Percentage Breakdown of Value Sales for
Surface Plasmon Resonance (SPR), Bio-layer Interferometry
(BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz
Crystal Microbalance for the Years 2012, 2020 & 2027
Table 100: Germany Current & Future Analysis for Label-free
Array Systems by Application - Drug Discovery, Antibody
Characterization and Development, Protein Interface Analysis
and Protein Complex and Cascade Analysis - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
Table 101: Germany Historic Review for Label-free Array Systems
by Application - Drug Discovery, Antibody Characterization and
Development, Protein Interface Analysis and Protein Complex and
Cascade Analysis Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019
Table 102: Germany 15-Year Perspective for Label-free Array
Systems by Application - Percentage Breakdown of Value Sales
for Drug Discovery, Antibody Characterization and Development,
Protein Interface Analysis and Protein Complex and Cascade
Analysis for the Years 2012, 2020 & 2027
Table 103: Germany Current & Future Analysis for Label-free
Array Systems by End-Use - R&D Laboratories, Contract Research
Organizations (CROs), Agriculture Research Institutes and Other
End-Uses - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027
Table 104: Germany Historic Review for Label-free Array Systems
by End-Use - R&D Laboratories, Contract Research Organizations
(CROs), Agriculture Research Institutes and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019
Table 105: Germany 15-Year Perspective for Label-free Array
Systems by End-Use - Percentage Breakdown of Value Sales for
R&D Laboratories, Contract Research Organizations (CROs),
Agriculture Research Institutes and Other End-Uses for the
Years 2012, 2020 & 2027
ITALY
Table 106: Italy Current & Future Analysis for Label-free Array
Systems by Technology - Surface Plasmon Resonance (SPR),
Bio-layer Interferometry (BLI), Cellular Dielectric
Spectroscopy (CDS) and Quartz Crystal Microbalance -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027
Table 107: Italy Historic Review for Label-free Array Systems
by Technology - Surface Plasmon Resonance (SPR), Bio-layer
Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS)
and Quartz Crystal Microbalance Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
Table 108: Italy 15-Year Perspective for Label-free Array
Systems by Technology - Percentage Breakdown of Value Sales for
Surface Plasmon Resonance (SPR), Bio-layer Interferometry
(BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz
Crystal Microbalance for the Years 2012, 2020 & 2027
Table 109: Italy Current & Future Analysis for Label-free Array
Systems by Application - Drug Discovery, Antibody
Characterization and Development, Protein Interface Analysis
and Protein Complex and Cascade Analysis - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
Table 110: Italy Historic Review for Label-free Array Systems
by Application - Drug Discovery, Antibody Characterization and
Development, Protein Interface Analysis and Protein Complex and
Cascade Analysis Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019
Table 111: Italy 15-Year Perspective for Label-free Array
Systems by Application - Percentage Breakdown of Value Sales
for Drug Discovery, Antibody Characterization and Development,
Protein Interface Analysis and Protein Complex and Cascade
Analysis for the Years 2012, 2020 & 2027
Table 112: Italy Current & Future Analysis for Label-free Array
Systems by End-Use - R&D Laboratories, Contract Research
Organizations (CROs), Agriculture Research Institutes and Other
End-Uses - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027
Table 113: Italy Historic Review for Label-free Array Systems
by End-Use - R&D Laboratories, Contract Research Organizations
(CROs), Agriculture Research Institutes and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019
Table 114: Italy 15-Year Perspective for Label-free Array
Systems by End-Use - Percentage Breakdown of Value Sales for
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05961007/?utm_source=PRN
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article